Phase IV, open-label, multicentre trial of afatinib in patients (pts) aged ≥70 yrs with NSCLC harbouring common (Del19/L858R) EGFR mutations: Preliminary results

K. L. Reckamp, P. Gilman, B. Halmos, M. Jahanzeb, J. McCann, H. Paripati, L. C. Seneviratne, J. A. Wallace, B. Rueter, A. Esler, E. Dowling, M. Koczywas

Research output: Contribution to journalArticle

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)viii527
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this